NEW YORK (GenomeWeb News) — Orchid Cellmark today said first-quarter revenue rose 12 percent, R&D spending inched up a hair, and losses receded 75 percent.
Total receipts for the three months ended March 31 increased to $14.1 million from $12.6 million year over year due mostly to an increase in forensic casework in the US and UK.
However, those gains were offset in part by a decrease in testing services to the Federal Bureau of Investigation.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.